EFB Dengue Literature Review

TNF-alpha

3 min read

TNF-alpha

Overview

Tumor necrosis factor alpha (TNF-α) is a pleiotropic pro-inflammatory cytokine with context-dependent roles in lymphoid tissue organisation. At physiological levels, TNF-α is required for primary B cell follicle development and follicular dendritic cell network formation. At elevated levels — as occur during cytokine storm in severe viral infections — TNF-α has been implicated in the disruption of germinal center formation and blockade of T follicular helper cell differentiation.

In this wiki, TNF-α is significant as the proposed mediator of GC disruption in COVID-19 and potentially in other infections with cytokine dysregulation (including severe dengue), linking innate immune activation to the dominance of extrafollicular B cell responses.

Key Points from Literature

  • Aberrant TNF-α accumulation in COVID-19 lymph nodes: Multi-color immunofluorescence showed TNF-α⁺ cells were markedly increased in COVID-19 LNs vs. activated tonsil controls (early COVID: p<0.05; late COVID: p<0.01). In controls, TNF-α was expressed at low levels localised to follicles; in COVID-19, it was expressed abundantly in both follicular and extra-follicular locations. The aberrant TNF-α distribution spatially overlaps with the site where pre-GC TFH cells differentiate into Bcl-6⁺ GC-TFH cells (the T-B interface), suggesting that excessive TNF-α at this location blocks the final step in TFH differentiation (see Kaneko2020 - GC Loss and TFH Block in COVID-19, n=5 early + 6 late COVID + 10 controls, multi-color immunofluorescence).
  • Murine precedent — TNF-α blockade rescues GC formation: The paper cites two murine models: (1) severe malaria (Ryg-Cornejo et al. 2016), where TNF-α blockade reversed defective TFH differentiation and restored GC responses; (2) Ehrlichia muris infection (Popescu et al. 2019), where both TNF-α blockade and genetic TNF-α deletion restored germinal centers. IFN-γ blockade also restored TFH and GCs in the malaria model, consistent with TH1 cells being upstream of TNF-α production. Together, these models establish that excessive TNF-α is sufficient to ablate GC formation via TFH blockade (see Kaneko2020 - GC Loss and TFH Block in COVID-19, citing murine studies).
  • Proposed mechanism: The differentiation of CD4⁺Bcl-6⁻CXCR5⁺ pre-GC TFH cells into CD4⁺Bcl-6⁺CXCR5⁺ GC-TFH cells occurs extra-follicularly at the T-B interface. High local TNF-α concentrations (possibly induced downstream of TH1 activation) at this site may block Bcl-6 expression transcriptionally or post-transcriptionally, preventing the final TFH maturation step and thus abrogating GC formation. The dual role of TNF-α — required for follicular development at low levels, destructive to GCs at high levels — is dose-dependent (see Kaneko2020 - GC Loss and TFH Block in COVID-19).

Contradictions & Debates

  • The contribution of TNF-α to GC loss is inferred from spatial co-localisation and murine precedent, not directly demonstrated in the COVID-19 human tissue. Other cytokines elevated in COVID-19 (IL-6, IFN-γ) could also contribute.
  • Whether TNF-α plays a similar GC-disruptive role in severe dengue is unknown. Dengue is associated with elevated TNF-α during the critical phase, and the low SHM in acute dengue IgG (GodoyLozano2016) is consistent with GC suppression — but no dengue lymph node histopathology study has been performed.

Bcl-6, Germinal Center, Extrafollicular Response, T-bet, IL-21

Sources

Graph View

Backlinks